Sodium Copper Chlorophyllins
Also known as: Sodium copper chlorophyllin, copper chlorophyllin, SCC, Sodium Copper Chlorophyllin
Overview
Sodium Copper Chlorophyllin (SCC) is a semi-synthetic, water-soluble derivative of natural chlorophyll, where the central magnesium ion is replaced by copper and the phytol tail is removed. It is commonly found in dietary supplements and used as a food colorant. SCC is primarily investigated for its antioxidant, anti-inflammatory, and potential chemopreventive properties. It has also shown promise in supporting hematopoietic function and modulating immune responses. Its key characteristics include strong antioxidant capacity, the ability to modulate inflammatory cytokines like IL-6 and TNF-α, and in vitro antiviral activity against certain viruses, including SARS-CoV-2. While preclinical studies and some small human trials exist, large-scale clinical trials are still needed to fully establish its efficacy and safety in humans. The current research maturity level is emerging, with moderate quality evidence primarily from preclinical and mechanistic studies.
Benefits
SCC exhibits several evidence-based benefits, primarily derived from preclinical studies and some human observations. It demonstrates significant anti-inflammatory effects by reducing pro-inflammatory cytokines such as IL-6 and TNF-α in vivo, with dose-dependent effects observed in animal models. In vitro studies have shown its antiviral activity against various viruses, including influenza and coronaviruses, suggesting potential in combating viral infections. SCC has also shown promise in hematopoietic support; a rat model of aplastic anemia demonstrated that SCC improved hemoglobin concentration, platelet counts, and bone marrow function, in some cases outperforming cyclosporine A. Furthermore, animal and cell studies indicate anticarcinogenic potential, as SCC can reduce oxidative damage and inhibit the absorption and metabolism of carcinogens, potentially lowering cancer risk. Secondary effects include possible improvement in immune regulation through modulation of T-cell subsets and inflammatory markers. These benefits suggest potential applications in viral respiratory infections, hematopoietic disorders, and as an adjunctive chemopreventive agent. While quantitative data from animal studies show significant improvements, human clinical effect sizes require further establishment through larger trials.
How it works
Sodium Copper Chlorophyllin (SCC) exerts its effects through multiple biological pathways. Its primary mechanism involves potent antioxidant activity, achieved by donating electrons and scavenging free radicals due to its copper-chelated porphyrin structure. Anti-inflammatory effects are mediated by the downregulation of pro-inflammatory cytokines like IL-6 and TNF-α, and the modulation of immune cell populations, including regulatory T cells (Tregs) and the CD4/CD8 ratio. SCC's antiviral properties may stem from direct viral inhibition and broader immune modulation. As a chemopreventive agent, it acts by binding to carcinogens in the gastrointestinal tract, inhibiting cytochrome P450 enzymes involved in carcinogen activation, and enhancing phase II detoxification enzymes. SCC and its derivatives are absorbed in the gastrointestinal tract, allowing them to interact with the immune system, support hematopoietic function, and contribute to the body's overall antioxidant defense.
Side effects
Sodium Copper Chlorophyllin (SCC) is generally regarded as safe at studied doses and is widely used as a food colorant and dietary supplement, with low reported toxicity. No major adverse effects have been reported in animal studies or small human trials. Common side effects are not well documented in clinical trials, and there is insufficient data to determine the prevalence of uncommon or rare side effects. Potential drug interactions are not well studied, but caution is advised regarding possible interactions with immunosuppressants or drugs metabolized by cytochrome P450 enzymes. Contraindications are not clearly established; however, due to a lack of comprehensive data, caution is recommended for immunocompromised individuals, pregnant, and breastfeeding populations. Further research is needed to fully understand its safety profile in these specific populations and to identify any long-term adverse effects or interactions.
Dosage
Optimal dosage ranges for Sodium Copper Chlorophyllin (SCC) are not yet firmly established in humans. Animal studies have shown effects at doses equivalent to 10-30 g/kg diet or 100 mg/kg body weight. In human trials for absorption studies and chemoprevention, doses of approximately 300 mg/day of oral SCC tablets have been used. This 300 mg/day dose is considered a potential starting point for human supplementation, based on its use in studies demonstrating absorption. The maximum safe dose for humans has not been clearly defined, though high doses in animal studies appear safe. Oral administration, potentially with meals, may improve absorption. Water-soluble tablet or powder forms are generally preferred for better bioavailability. SCC is absorbed in the gastrointestinal tract, but some degradation can occur, and absorption may be influenced by the food matrix and chemical form. No specific cofactors are identified as required for its efficacy.
FAQs
Is SCC safe for long-term use?
While generally considered safe based on available data, long-term human studies on SCC are limited, so definitive conclusions about its safety for extended use cannot be made.
Can SCC be used to treat viral infections?
In vitro studies show SCC has antiviral activity, but its clinical efficacy in treating human viral infections has not yet been proven in large-scale human trials.
How quickly does SCC work?
SCC is absorbed within hours of ingestion. In animal models, clinical benefits have been observed within weeks of consistent supplementation.
Does SCC cause side effects?
No significant side effects have been reported in the available preclinical and small human studies, suggesting a generally good safety profile at studied doses.
Is SCC better than other chlorophyll derivatives?
SCC is more water-soluble and potentially more bioavailable than native chlorophyll. However, comparative clinical efficacy between SCC and other chlorophyll derivatives is not yet clear.
Research Sources
- https://article.innovationforever.com/JMBDD/20230008.html – This review summarizes the antioxidant, anti-inflammatory, and antiviral properties of SCC, drawing primarily from preclinical data. It highlights the potential therapeutic applications of SCC but emphasizes the need for more extensive human clinical trials to validate these findings.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10384064/ – This review discusses the chemopreventive potential of SCC and includes data from a small human study demonstrating its absorption in human volunteers. It provides insights into the pharmacokinetics of SCC but notes the lack of large-scale clinical efficacy data.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9007642/ – This randomized controlled trial in rats with aplastic anemia showed that SCC significantly improved hematopoietic parameters and immune function, outperforming cyclosporine A in some aspects. The study provides strong preclinical evidence for SCC's role in blood disorders, though human relevance needs further investigation.
- https://biointerfaceresearch.com/wp-content/uploads/2020/01/20695837102993010.pdf – This systematic review and meta-analysis of animal studies concludes that SCC exhibits significant antioxidant and anticarcinogenic effects, primarily by reducing carcinogen bioavailability. It consolidates preclinical evidence supporting SCC's protective roles, while acknowledging the absence of human randomized controlled trials.
